Search PubMed⌕ Search

Biomedical subjects

N B Atkin

Publications and source records attributed to N B Atkin.

At least 55 records · Page 3Linked to original sources

Prognostic value of ovarian carcinoma grading methods--a method comparison study.

The prognostic value of subjective histological and morphometric grading was studied in 75 primary ovarian carcinomas. Histological grading methods recommended by Czernobilsky and by Russell and the morphometric method of Baak and co-workers were compared in a two-observer system. The 5-year survival could be correctly predicted in about two-thirds of the patients with all three methods. When mitotic counting (volume corrected mitotic index, M/V-index) was compared with the above grading methods by using a receiver operating characteristic curve) the M/V-index was generally superior in its prognostic power regardless of the sensitivity/specificity level chosen. The morphometric grading method and the grading method based on the M/V index were also shown to be readily reproducible.

Carcinoma↗

Solid tumor cytogenetics. Progress since 1979.

Some of the advances in the past decade in the field of solid tumor cytogenetics are described, with particular reference to nonrandom structural chromosome changes. Although it had been known for many years that meningiomas and salivary gland tumors were associated with changes involving particular chromosomes, it has only quite recently become clear, following the application of suitable culture techniques, that other benign tumors such as lipomas and leiomyomas may also be characterized by specific changes, particularly reciprocal translocations. Reciprocal translocations may also be found in malignant soft-tissue tumors such as liposarcomas (involving 12q as in lipomas) and Ewing's sarcoma. In contrast, the common forms of carcinoma present a more variable picture, although certain chromosomes may undergo nonrandom changes of various types, including translocations, which, however, are generally nonreciprocal. Some of these chromosomes may be quite specific (e.g., chromosome 10 in prostatic and #18 in colorectal cancer), while others appear to be common to many or all types of carcinoma, such as chromosomes 1, 3, 11, and 17, and a small metacentric that may be an i(5p). In carcinoma of the bladder, different chromosome changes may characterize subsets of the tumors. In carcinoma of the cervix, however, the commonly involved chromosomes, 1, 3, ?5, 11, and 17, appear in markers in any combination and are thus not mutually exclusive. Although further study of the chromosome changes in carcinomas is essential to an understanding of their relationship to the molecular changes that are associated with malignant transformation, it can be hypothesized that, while some of the changes result in the duplication of particular genes, e.g., on chromosome 1q, a more important role may be to bring about the loss of chromosomal segments containing tumor-suppressor genes. Evidence from molecular studies that has recently been accumulating for the loss of alleles on, for instance, 3p, 11p, and 17p, which could in part be due to gross chromosomal rearrangements, also strongly suggests the importance of genic loss in malignant transformation. In carcinomas, at least, the changes probably involve a number of genes, each change representing one of the several steps necessary for tumorigenesis.

Chromosome Aberrations↗

Chromosome 17p loss in carcinoma of the cervix uteri.

Markers derived from chromosome 17 were present in 13 (42%) of 31 carcinomas of the cervix uteri. Altogether, 14 such markers were present, ten of which were 17p+ chromosomes with a small amount of additional material, probably of variable origin, while three were i(17q)s. The significance of the chromosome 17 aberrations in cervical carcinoma may lie in the loss of recessive genes on 17p.

Carcinoma↗

Prognosis of ovarian carcinomas: prediction by histoquantitative methods.

Prediction of prognosis of ovarian carcinomas by morphometric, histopathological and clinical indices was estimated in 105 tumours. Morphometric parameters included mitotic activity index, volume-corrected mitotic index (M/V index), volume fraction of neoplastic epithelium, nuclear area, nuclear perimeter, shortest and longest nuclear axis and form factor of nucleus. Cox's multivariate regression model showed that the clinical stage was the best predictor of prognosis followed by the M/V index, which expresses the mitotic activity as the number of mitotic figures per square millimeter of neoplastic epithelium in the microscope field. In all tumour subgroups studied the M/V index was the best prognostic factor and for stage I tumours it was the only parameter selected by the Cox's model as a significant and independent prognostic predictor. We conclude that the M/V index can be used as a significant prognostic factor in ovarian carcinomas.

Carcinoma↗

Value of aceto-orcein squash preparations in the cytogenetic study of solid tumours.

The value of aceto-orcein squash preparations as a routine initial step in the cytogenetic study of solid tumours is pointed out. This simple procedure allows a rapid evaluation to be made of various characteristics of the tumour, including the ploidy level, as well as a definitive assessment of nuclear phenomena including the incidence of X-chromatin bodies. Evaluation of the latter in normal as well as tumour cells led to the discovery of unsuspected congenital sex chromosome anomalies in two patients in this laboratory.

Adenocarcinoma↗

A comparison of the number of X-chromatin bodies and of X chromosomes in carcinomas of the cervix uteri.

The number of X-chromatin bodies in interphase cells was compared with the number of X chromosomes in metaphases in nineteen carcinomas of the cervix uteri. This is the first time that such a direct comparison has been made. Nine tumours had a single X-chromatin body, four had two bodies and six were X-chromatin negative. Thus, a total of seventeen X-chromatin bodies was present in these tumours which collectively had forty-seven X chromosomes. Surprisingly, three tumours with near diploid complements were X-chromatin negative although they had two X chromosomes. The findings suggest that duplication of the active X is advantageous during tumour development while the inactive, X-chromatin forming, X chromosome tends to be lost.

Adult↗

Small metacentric marker chromosomes, particularly isochromosomes, in cancer.

At least two types of small metacentrics, which are isochromosomes for 12p and either 4p or 5p, respectively, are significantly associated with certain types of cancer and their formation may represent important stages in the development of these tumours. The specificity of the i(12p) for testicular cancer is now well established (it may also be present, however, in dysgerminomas and mixed Müllerian tumours of the ovary). This review is therefore mainly concerned with another marker, probably an i(5p) although an i(4p) should also be considered. Recent data suggest that this marker represents a significant chromosomal change occurring with a fairly high frequency in a variety of cancers, including carcinomas of the cervix, ovary, breast, bladder and bronchus (excluding small-cell carcinomas). These isochromosomes may contribute to tumour development through gene amplification; consistent with this is the frequent presence of these markers in two or more copies.

Chromosome Aberrations↗

Squamous cell carcinoma of the skin with an unusual marker chromosome.

Chromosome studies were undertaken on uncultured material from a primary anaplastic squamous cell carcinoma of the skin from a female aged 81. The modal chromosome number was 42. Four marker chromosomes were present in most metaphases: a der (1) which resulted in tetrasomy for most of 1q, a giant chromosome consisting of most of a chromosome 2 and 4q, a small metacentric which was probably an isochromosome for 4p or 5p, and a small chromosome, considered to be an 18q+. The latter was conspicuous in unbanded orcein-stained preparations owing to the presence of a virtually nonstaining region on its long arm. These findings are of interest in the light of the paucity of data on this type of tumour.

Aged↗

Abnormal chromosomes including small metacentrics in 14 ovarian cancers.

In direct preparations of 14 ovarian cancers including 11 primary tumors, chromosomes #1 (12 tumors), #3 (12 tumors, including 3q- chromosomes in five), #6 [eight tumors, including six with a 6q- and two with an i(6p)], #11 (11p + in seven tumors), and #14 (14q+ in at least seven tumors) were most frequently involved in structural aberrations. Also, abnormal small metacentrics were seen in 11 tumors. In ten of these the chromosome appeared to be an i(4p) or i(5p) and in one of these, a mixed Müllerian tumor, there was also an i(12p); the latter anomaly was also present (in duplicate) in a dysgerminoma.

Adult↗

Cytophotometric DNA determination correlated to karyotype, particularly in cancer.

Variation from the normal in the distribution patterns of the DNA content of interphase tumor cells is considered in relation to the chromosome abnormalities that occur in these cells. The possible diagnostic and prognostic significance of the DNA distributions, particularly the modal values, of human tumors is discussed. Tumors with normal or near-normal modes frequently have a favorable prognosis, but this is not true for all tumor sites or types, including squamous-cell carcinomas of the cervix uteri and carcinomas of the large bowel, in which near-triploid tumors may have a relatively favorable prognosis.

Animals↗

Chromosome 1 aberrations in cancer.

Evidence for chromosome #1 involvement in structural rearrangements in cancer is reviewed. There have been adequate studies of cancer at most of the common sites, and at all of these, nonrandom chromosome #1 involvement has been demonstrated. In general, a variety of changes is encountered, irrespective of the site; most commonly, however, the changes result in the duplication of long arm material. It seems that these nonrandom changes, which tend to occur at a relatively late stage, may contribute to the progression of all forms of cancer. However, a small number of chromosome #1 aberrations are also now known, which may represent specific and possibly initiating changes in particular forms of cancer. These include short arm deletions in neuroblastoma and translocations in leukemias and myelodysplasia.

Chromosome Aberrations↗

Lack of reciprocal translocations in carcinomas.

Among the varied structural chromosomal aberrations present in the common forms of carcinoma, reciprocal translocations generally appear to be lacking. Although the breakpoints may be variable, the chromosomal changes nevertheless commonly result in the loss or gain of particular chromosomal segments. The possible implications of these observations are discussed, especially in relation to the thesis that some of the chromosomal changes in cancer cells are important because they lead to the expression of recessive genes.

Carcinoma↗

Antioncogenes.

Explore the source record for details and available documents.

Humans↗